Archive: March 2024
Feature Article
Management of KRAS-Mutated Non–Small Cell Lung Cancer
Abstract: Kirsten rat sarcoma virus (KRAS) is the most frequently mutated oncogene in human cancers, particularly in non–small cell lung cancer (NSCLC), where mutations are present […]
Feature Article
Recombinant Interferon Alfa in BCR/ABL-Negative Chronic Myeloproliferative Neoplasms
Abstract: The treatment landscape for BCR/ABL-negative myeloproliferative neoplasms (MPNs), driven by JAK2, CALR, and MPL mutations, has evolved significantly over the last decade. Recent regulatory approvals […]
Advances in LLM
Epcoritamab, a Promising Therapy for Richter Syndrome?
H&O What defines Richter syndrome? AK Richter syndrome (RS), also known as Richter transformation, refers to the development of an aggressive lymphoma in the setting of […]